InsidersTradesSigma
Track the 生物股份 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 生物股份 has published 2 reports. Market capitalisation: €12.9bn. The latest transaction was reported on 22 April 2022 (Purchase). Among the most active insiders: 张翀宇. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
生物股份是一家在上海证券交易所上市的医疗保健和制药公司。它专注于生物制药产品的开发和生产。